Clinical trial
Evaluation of a Heterologous, Two-dose Preventive Ebola Vaccine for Effectiveness and Safety in the Democratic Republic of the Congo
NCT04152486 is registered in ClinicalTrials.gov with London School of Hygiene and Tropical Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of a Heterologous, Two-dose Preventive Ebola Vaccine for Effectiveness and Safety in the Democratic Republic of the Congo
- Lead sponsor
- London School of Hygiene and Tropical Medicine
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- November 14, 2019
- Completion date
- February 28, 2022
- Enrollment
- 20,426 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ebola virus disease